MentionFox
Home › funding signals › Hepion Pharmaceuticals, Inc.
Company · SEC filings

Hepion Pharmaceuticals, Inc. funding history

Hepion Pharmaceuticals, Inc. has 5 Form D filings on record, from 2022-11-15 to 2026-08-05. Together its new offerings report $3.75M sold.

Funding historyFounders and team

What do you want to do with Hepion Pharmaceuticals, Inc.?

Based
RED BANK, NEW JERSEY
Industry group
Biotechnology
Filings
5
Raised (new offerings)
$3.75M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-08-05New offering
first sale 2026-07-31
$3.06M$3.06MSEC filing
2026-04-22New offering
first sale 2026-04-21
$700K$700KSEC filing
2024-07-24Filing——SEC filing
2023-10-03Filing——SEC filing
2022-11-15Filing——SEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Hepion Pharmaceuticals, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/hepion-pharmaceuticals-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Hepion Pharmaceuticals, Inc. funding history: 5 SEC filings, $3.75M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/hepion-pharmaceuticals-inc